352 The risks of secondary cancers from radioactive iodine treatment

  Рет қаралды 776

ThyCa: Thyroid Cancer Survivors' Association, Inc.

ThyCa: Thyroid Cancer Survivors' Association, Inc.

6 ай бұрын

352 The risks of secondary cancers from radioactive iodine treatment. Presented by Erik Blomain, MD, PhD, Radiation Oncologist and Patient Advocate. This video was recorded during the 26th International Thyroid Cancer Survivors' Conference that was held Oct 13-15, 2023 in Denver, Colorado, USA. This event was hosted by ThyCa: Thyroid Cancer Survivors' Association, Inc. The content is not to be used as medical advice, but rather as education. Please seek the care of your own medical team.

Пікірлер
336 Ethanol ablation roundtable: Patients share their experiences
33:13
ThyCa: Thyroid Cancer Survivors' Association, Inc.
Рет қаралды 133
The risks of secondary cancers from radioactive iodine treatment. 162
58:21
ThyCa: Thyroid Cancer Survivors' Association, Inc.
Рет қаралды 4,1 М.
Dad gives best memory keeper
01:00
Justin Flom
Рет қаралды 21 МЛН
PEDRO PEDRO INSIDEOUT
00:10
MOOMOO STUDIO [무무 스튜디오]
Рет қаралды 27 МЛН
АЗАРТНИК 4 |СЕЗОН 2 Серия
31:45
Inter Production
Рет қаралды 903 М.
355 Radioactive Iodine: Mgmt of side effects & safety guidelines after you leave the dosing center.
57:32
ThyCa: Thyroid Cancer Survivors' Association, Inc.
Рет қаралды 764
Circulating Tumor DNA: Liquid Gold
26:31
AIMatMelanoma
Рет қаралды 1,1 М.
An Overview of Radiation Oncology
50:30
Freeman Professional Development
Рет қаралды 42 М.
351 The importance of lifetime follow-up
1:00:36
ThyCa: Thyroid Cancer Survivors' Association, Inc.
Рет қаралды 387
321 What is radiation oncology and how is it used in our thyroid cancer journey?
1:03:45
ThyCa: Thyroid Cancer Survivors' Association, Inc.
Рет қаралды 208
341 Working with your physician to determine the best treatment for you.
31:21
ThyCa: Thyroid Cancer Survivors' Association, Inc.
Рет қаралды 220
342 Understanding thyroid hormone replacement therapy...Preparations, dosing, monitoring, TSH target
59:52
ThyCa: Thyroid Cancer Survivors' Association, Inc.
Рет қаралды 574
Stanford Cancer Institute Breakthroughs in Cancer: David Hong, MD
1:01:53
Stanford Cancer Institute
Рет қаралды 8 М.